|
Index of reports
> Death (40)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Epirubicin death. The selected reports were submitted to the FDA during the sample period of about a year. Reports 1 - 30 of 40 Next >>
Possible Epirubicin side effects in male
Reported by a physician from United Kingdom on 2012-08-23
Patient: male, weighing 82.0 kg (180.4 pounds)
Reactions: Coronary Artery Disease
Adverse event resulted in: death
Drug(s) suspected as cause:
Epirubicin
Dosage: most recent dose: 02/may/2012; most recent dose: 96 mg
Indication: Gastric Cancer
Start date: 2012-03-21
Xeloda
Dosage: most recent dose: 09/may/2012 and most recent dose: 2500 mg daily
Administration route: Oral
Indication: Gastric Cancer
Start date: 2012-03-21
Cisplatin
Dosage: most recent dose: 02/may/2012; most recent dose: 110 mg
Indication: Gastric Cancer
Start date: 2012-03-21
Avastin
Dosage: most recent dose: 02/may/2012; most recent dose: 577 mg
Indication: Gastric Cancer
Start date: 2012-03-21
Possible Epirubicin side effects in 35 year old female
Reported by a physician from Philippines on 2012-08-16
Patient: 35 year old female, weighing 56.2 kg (123.6 pounds)
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Epirubicin
Dosage: form:vialtotal dose recieved:140 mg
Start date: 2010-11-04
Docetaxel
Dosage: form:vialtotal dose recieved:152 mg
Start date: 2010-09-02
Trastuzumab
Dosage: form:vialtotal dose recieved:336 mg
Start date: 2011-07-21
Fluorouracil
Dosage: form:vial
Start date: 2010-11-04
Trastuzumab
Dosage: form:vial
Cyclophosphamide
Dosage: form:vialtotal dose recieved:936 mg
Start date: 2010-11-04
Possible Epirubicin side effects in 35 year old female
Reported by a physician from Philippines on 2012-08-09
Patient: 35 year old female, weighing 56.2 kg (123.6 pounds)
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Trastuzumab
Dosage: form:vial
Epirubicin
Dosage: form:vialtotal dose recieved:140 mg
Start date: 2010-11-04
Trastuzumab
Dosage: form:vialtotal dose recieved:336 mg
Start date: 2011-07-21
Docetaxel
Dosage: form:vialtotal dose recieved:152 mg
Start date: 2010-09-02
Cyclophosphamide
Dosage: form:vialtotal dose recieved:936 mg
Start date: 2010-11-04
Fluorouracil
Dosage: form:vial
Start date: 2010-11-04
Possible Epirubicin side effects in male
Reported by a physician from Poland on 2012-07-24
Patient: male, weighing 77.0 kg (169.4 pounds)
Reactions: Dyspnoea, Pleural Effusion, Palmar-Plantar Erythrodysaesthesia Syndrome, General Physical Health Deterioration, Neutropenia, Polyneuropathy, Disease Progression
Adverse event resulted in: death
Drug(s) suspected as cause:
Epirubicin
Indication: Metastatic Gastric Cancer
Start date: 2010-10-27
End date: 2011-04-06
Capecitabine
Indication: Metastatic Gastric Cancer
Start date: 2010-10-27
End date: 2011-04-06
Oxaliplatin
Indication: Metastatic Gastric Cancer
Start date: 2010-10-27
End date: 2011-04-06
Possible Epirubicin side effects in 58 year old female
Reported by a physician from Taiwan, Province of China on 2012-07-24
Patient: 58 year old female, weighing 57.3 kg (126.1 pounds)
Reactions: Multi-Organ Failure, Pneumonia, Coagulopathy, Central Nervous System Lesion, Acute Respiratory Distress Syndrome, Neutropenia, Acute Respiratory Failure, Renal Failure Acute
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Epirubicin
Start date: 2010-12-28
End date: 2010-12-28
Taxotere
Indication: Breast Cancer
Start date: 2010-09-30
End date: 2010-09-30
Taxotere
Start date: 2010-12-28
End date: 2010-12-28
Epirubicin
Indication: Breast Cancer
Start date: 2010-09-30
End date: 2010-09-30
Other drugs received by patient: Granocyte
Possible Epirubicin side effects in 44 year old female
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-20
Patient: 44 year old female, weighing 55.5 kg (122.1 pounds)
Reactions: Abdominal Pain, Intestinal Ischaemia, Colitis Ischaemic, White Blood Cell Count Decreased, Vomiting, Blood Creatine Phosphokinase Increased, Gastrointestinal Necrosis, Pyrexia, Multi-Organ Failure, Diarrhoea, GAS Gangrene, Heart Rate Increased, Bone Marrow Failure, Neutropenia, Clostridial Infection
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 7 cycles, total 4 courses
Indication: Breast Cancer
Start date: 2011-07-22
End date: 2011-09-22
Epirubicin
Dosage: 7 cycles, total 4 courses
Indication: Breast Cancer
Start date: 2011-07-22
End date: 2011-09-22
Taxotere
Dosage: 4 cycles, total 3 courses, dose taken once daily
Indication: Breast Cancer
Start date: 2011-10-14
End date: 2011-11-25
Other drugs received by patient: Leucon; Lorazepam; Decadron Phosphate; Lorazepam; Kytril; Prochlorperazine; Kytril; Cepharanthin; Decadron Phosphate; Marzulene S
Possible Epirubicin side effects in 50 year old female
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-02
Patient: 50 year old female
Reactions: Acute Myeloid Leukaemia
Adverse event resulted in: death
Drug(s) suspected as cause:
Epirubicin
Dosage: received eight courses.
Therapeutic Radiopharmaceuticals
Dosage: received 50 gy of irradiation to conserved breast and supraclavicular fossa
Cyclophosphamide
Dosage: received eight courses.
Docetaxel
Dosage: eight courses.
Possible Epirubicin side effects in 63 year old male
Reported by a physician from Poland on 2012-06-27
Patient: 63 year old male
Reactions: Dyspnoea, Palmar-Plantar Erythrodysaesthesia Syndrome, Pleural Effusion, General Physical Health Deterioration, Neutropenia, Polyneuropathy, Disease Progression
Adverse event resulted in: death
Drug(s) suspected as cause:
Oxaliplatin
Indication: Product Used FOR Unknown Indication
Capecitabine
Indication: Product Used FOR Unknown Indication
Epirubicin
Indication: Product Used FOR Unknown Indication
Possible Epirubicin side effects in female
Reported by a health professional (non-physician/pharmacist) from France on 2012-06-15
Patient: female
Reactions: Breast Cancer, Maternal Exposure During Pregnancy
Adverse event resulted in: death
Drug(s) suspected as cause:
Epirubicin
Indication: Breast Cancer
Start date: 2007-01-01
End date: 2007-01-01
Cyclophosphamide
Indication: Breast Cancer
Start date: 2007-01-01
End date: 2007-01-01
Fluorouracil
Indication: Breast Cancer
Start date: 2007-01-01
End date: 2007-01-01
Possible Epirubicin side effects in 68 year old female
Reported by a physician from Japan on 2012-06-15
Patient: 68 year old female, weighing 39.9 kg (87.8 pounds)
Reactions: White Blood Cell Count Decreased, Dyspnoea, Nausea, Hypotension, Tachycardia, Toxic Epidermal Necrolysis, Pyrexia, Haemoglobin Decreased, Respiratory Failure, Circulatory Collapse, Neutropenia, Rash Vesicular, Oxygen Saturation Decreased, Shock
Adverse event resulted in: death
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Breast Cancer
Start date: 2012-02-28
End date: 2012-02-28
Epirubicin
Indication: Breast Cancer
Start date: 2012-02-28
End date: 2012-02-28
Possible Epirubicin side effects in 35 year old female
Reported by a physician from Philippines on 2012-06-01
Patient: 35 year old female, weighing 56.2 kg (123.6 pounds)
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Fluorouracil
Dosage: form:vial
Start date: 2010-11-04
Trastuzumab
Dosage: form:vialtotal dose recieved:336 mg
Start date: 2011-07-21
Docetaxel
Dosage: form:vialtotal dose recieved:152 mg
Start date: 2010-09-02
Epirubicin
Dosage: form:vialtotal dose recieved:140 mg
Start date: 2010-11-04
Cyclophosphamide
Dosage: form:vialtotal dose recieved:936 mg
Start date: 2010-11-04
Trastuzumab
Dosage: form:vial
Possible Epirubicin side effects in 49 year old female
Reported by a health professional (non-physician/pharmacist) from Taiwan, Province of China on 2012-05-31
Patient: 49 year old female
Reactions: Multi-Organ Failure, Acute Lymphocytic Leukaemia, Pneumonia, Dizziness, Pancytopenia, Septic Shock, Asthenia, Decreased Appetite
Adverse event resulted in: death
Drug(s) suspected as cause:
Epirubicin
Indication: Breast Cancer Stage II
Fluorouracil
Indication: Breast Cancer Stage II
Cyclophosphamide
Indication: Breast Cancer Stage II
Prednisolone
Other drugs received by patient: Cytarabine; Vincristine; Doxorubicin HCL; Dexamethasone; Methotrexate
Possible Epirubicin side effects in 49 year old female
Reported by a health professional (non-physician/pharmacist) from Taiwan, Province of China on 2012-05-30
Patient: 49 year old female
Reactions: Multi-Organ Failure, Lymphocytosis, Acute Lymphocytic Leukaemia, Refractory Anaemia, Pneumonia, Septic Shock
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Methotrexate
Indication: Acute Lymphocytic Leukaemia
Start date: 2009-07-01
Vincristine
Indication: Acute Lymphocytic Leukaemia
Start date: 2009-07-01
Doxorubicin HCL
Indication: Acute Lymphocytic Leukaemia
Start date: 2009-07-01
Cytarabine
Indication: Acute Lymphocytic Leukaemia
Start date: 2009-07-01
Cyclophosphamide
Dosage: 100 mg
Administration route: Oral
Indication: Anaemia
Prednisolone
Indication: Leukocytosis
Fluorouracil
Indication: Breast Cancer
Dexamethasone
Indication: Acute Lymphocytic Leukaemia
Start date: 2009-07-01
Cyclophosphamide
Indication: Breast Cancer
Cyclophosphamide
Indication: Leukocytosis
Start date: 2009-07-01
Epirubicin
Indication: Breast Cancer
Prednisolone
Dosage: 15 mg
Indication: Anaemia
Cyclophosphamide
Indication: Acute Lymphocytic Leukaemia
Possible Epirubicin side effects in 67 year old male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-05-29
Patient: 67 year old male, weighing 85.0 kg (187.0 pounds)
Reactions: Gastrointestinal Anastomotic Leak, Respiratory Disorder, Atrial Fibrillation, Diaphragmatic Hernia, Post Procedural Haemorrhage
Adverse event resulted in: death
Drug(s) suspected as cause:
Epirubicin
Indication: Gastric Cancer
Start date: 2011-09-22
Bevacizumab
Start date: 2011-11-17
Capecitabine
Administration route: Oral
Start date: 2011-12-08
Cisplatin
Start date: 2011-11-17
Cisplatin
Indication: Gastric Cancer
Start date: 2011-09-22
Epirubicin
Start date: 2011-11-17
Capecitabine
Administration route: Oral
Indication: Gastric Cancer
Start date: 2011-09-22
Bevacizumab
Indication: Gastric Cancer
Start date: 2011-09-22
Possible Epirubicin side effects in 49 year old female
Reported by a health professional (non-physician/pharmacist) from Taiwan, Province of China on 2012-05-28
Patient: 49 year old female
Reactions: Pneumonia, B Precursor Type Acute Leukaemia
Adverse event resulted in: death
Drug(s) suspected as cause:
Epirubicin
Indication: Breast Cancer
Cytarabine
Indication: Breast Cancer
Vincristine
Indication: Breast Cancer
Cyclophosphamide
Indication: Breast Cancer
Doxorubicin HCL
Indication: Breast Cancer
Fluorouracil
Indication: Breast Cancer
Methotrexate
Indication: Breast Cancer
Dexamethasone
Indication: Breast Cancer
Possible Epirubicin side effects in female
Reported by a individual with unspecified qualification from United States on 2012-05-25
Patient: female
Reactions: Sudden Cardiac Death, Cardiac Failure Congestive
Adverse event resulted in: death
Drug(s) suspected as cause:
Epirubicin
Indication: Breast Cancer
Paclitaxel
Indication: Breast Cancer
Cyclophosphamide
Indication: Breast Cancer
Paclitaxel
Fluorouracil
Indication: Breast Cancer
Trastuzumab
Trastuzumab
Indication: Breast Cancer
Possible Epirubicin side effects in 49 year old female
Reported by a health professional (non-physician/pharmacist) from Taiwan, Province of China on 2012-05-25
Patient: 49 year old female
Reactions: Acute Lymphocytic Leukaemia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Breast Cancer Stage II
Fluorouracil
Indication: Breast Cancer Stage II
Epirubicin
Indication: Breast Cancer Stage II
Possible Epirubicin side effects in 35 year old male
Reported by a individual with unspecified qualification from Norway on 2012-05-24
Patient: 35 year old male
Reactions: Neoplasm Malignant, Drug Ineffective
Adverse event resulted in: death
Drug(s) suspected as cause:
Xeloda
Administration route: Oral
Indication: Oesophageal Adenocarcinoma
Epirubicin
Indication: Oesophageal Adenocarcinoma
Oxaliplatin
Indication: Oesophageal Adenocarcinoma
Possible Epirubicin side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-23
Patient: female
Reactions: Cardiac Failure Congestive
Adverse event resulted in: death
Drug(s) suspected as cause:
Fluorouracil
Dosage: dose unit:500
Indication: Breast Cancer
Paclitaxel
Indication: Breast Cancer
Trastuzumab
Trastuzumab
Indication: Breast Cancer
Epirubicin
Dosage: dose unit:75
Indication: Breast Cancer
Cyclophosphamide
Dosage: dose unit:500
Indication: Breast Cancer
Possible Epirubicin side effects in 49 year old female
Reported by a health professional (non-physician/pharmacist) from Taiwan, Province of China on 2012-05-22
Patient: 49 year old female
Reactions: Acute Lymphocytic Leukaemia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Epirubicin
Indication: Breast Cancer Stage II
Cytoxan
Indication: Breast Cancer Stage II
Fluorouracil
Indication: Breast Cancer Stage II
Possible Epirubicin side effects in 49 year old female
Reported by a health professional (non-physician/pharmacist) from Taiwan, Province of China on 2012-05-18
Patient: 49 year old female
Reactions: Pneumonia, Anaemia, Pancytopenia, Pyrexia, B Precursor Type Acute Leukaemia, Multi-Organ Failure, Death, Lymphocytosis, Dizziness, Asthenia, Septic Shock, Leukocytosis, Decreased Appetite
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cytoxan
Dosage: 100 mg, unk
Indication: Breast Cancer Stage II
Start date: 2008-03-01
Epirubicin
Indication: Breast Cancer Stage II
Start date: 2008-03-01
Fluorouracil
Indication: Breast Cancer Stage II
Start date: 2008-03-01
Possible Epirubicin side effects in 67 year old male
Reported by a consumer/non-health professional from United Kingdom on 2012-05-18
Patient: 67 year old male, weighing 85.0 kg (187.0 pounds)
Reactions: Gastrointestinal Anastomotic Leak, Post Procedural Haemorrhage
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Capecitabine
Dosage: 5250 mg, unk
Administration route: Oral
Start date: 2011-12-08
Cisplatin
Dosage: unk
Indication: Gastric Cancer
Start date: 2011-09-22
Bevacizumab
Dosage: 655 mg, unk
Start date: 2011-11-17
Capecitabine
Dosage: unk
Administration route: Oral
Indication: Gastric Cancer
Start date: 2011-09-22
Cisplatin
Dosage: 120 mg, unk
Start date: 2011-11-17
Epirubicin
Dosage: unk
Indication: Gastric Cancer
Start date: 2011-09-22
Bevacizumab
Dosage: unk
Indication: Gastric Cancer
Start date: 2011-09-22
Epirubicin
Dosage: 50 mg, unk
Start date: 2011-11-17
Possible Epirubicin side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-17
Patient: female
Reactions: B-Cell Lymphoma
Adverse event resulted in: death
Drug(s) suspected as cause:
Epirubicin
Indication: B-Cell Lymphoma
Start date: 2010-05-11
Rituxan
Indication: B-Cell Lymphoma
Start date: 2010-05-11
Cytoxan
Indication: B-Cell Lymphoma
Start date: 2010-05-11
Possible Epirubicin side effects in 49 year old female
Reported by a health professional (non-physician/pharmacist) from Taiwan, Province of China on 2012-05-15
Patient: 49 year old female
Reactions: Pneumonia, Anaemia, Pancytopenia, Pyrexia, B Precursor Type Acute Leukaemia, Lymphocytosis, Multi-Organ Failure, Death, Dizziness, Septic Shock, Asthenia, Leukocytosis, Decreased Appetite
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Breast Cancer Stage II
Start date: 2008-03-01
Fluorouracil
Indication: Breast Cancer Stage II
Start date: 2008-03-01
Epirubicin
Indication: Breast Cancer Stage II
Start date: 2008-03-01
Possible Epirubicin side effects in 68 year old female
Reported by a physician from Japan on 2012-05-04
Patient: 68 year old female, weighing 39.9 kg (87.8 pounds)
Reactions: White Blood Cell Count Decreased, Dyspnoea, Nausea, Hypotension, Tachycardia, Toxic Epidermal Necrolysis, Pyrexia, Haemoglobin Decreased, Respiratory Failure, Circulatory Collapse, Neutropenia, Rash Vesicular, Oxygen Saturation Decreased, Shock
Adverse event resulted in: death
Drug(s) suspected as cause:
Epirubicin
Indication: Breast Cancer
Start date: 2012-02-28
End date: 2012-02-28
Cyclophosphamide
Indication: Breast Cancer
Start date: 2012-02-28
End date: 2012-02-28
Possible Epirubicin side effects in 48 year old female
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-04-26
Patient: 48 year old female
Reactions: Respiratory Failure, Pneumothorax, Pulmonary Fibrosis
Adverse event resulted in: death
Drug(s) suspected as cause:
Epirubicin
Indication: Breast Cancer
Fluorouracil
Indication: Breast Cancer
Cyclophosphamide
Indication: Breast Cancer
Possible Epirubicin side effects in female
Reported by a physician from Finland on 2012-04-23
Patient: female
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Epirubicin
Dosage: on day 1
Indication: Breast Cancer
Docetaxel
Dosage: on day 1 as 1-hr intravenous infusion
Indication: Breast Cancer
Cyclophosphamide
Dosage: on day 1
Indication: Breast Cancer
Fluorouracil
Dosage: on day 1
Indication: Breast Cancer
Other drugs received by patient: Corticosteroids
Possible Epirubicin side effects in female
Reported by a physician from Finland on 2012-04-23
Patient: female
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: on day 1
Indication: Breast Cancer
Capecitabine
Dosage: first dose administered on day 1 evening and last dose administered on day 15 morning every 3 weeks.
Administration route: Oral
Indication: Breast Cancer
Docetaxel
Dosage: on day 1 as 1-hr intravenous infusion
Indication: Breast Cancer
Epirubicin
Dosage: on day 1
Indication: Breast Cancer
Capecitabine
Dosage: first dose administered on day 1 evening and last dose administered on day 15 morning every 3 weeks.
Administration route: Oral
Other drugs received by patient: Corticosteroids
Possible Epirubicin side effects in 35 year old female
Reported by a physician from Philippines on 2012-04-02
Patient: 35 year old female, weighing 56.2 kg (123.6 pounds)
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Trastuzumab
Dosage: form:vialtotal dose recieved:336 mg
Start date: 2011-07-21
Fluorouracil
Dosage: form:vial
Start date: 2010-11-04
Trastuzumab
Dosage: form:vial
Epirubicin
Dosage: form:vialtotal dose recieved:140 mg
Start date: 2010-11-04
Cyclophosphamide
Dosage: form:vialtotal dose recieved:936 mg
Start date: 2010-11-04
Docetaxel
Dosage: form:vialtotal dose recieved:152 mg
Start date: 2010-09-02
Possible Epirubicin side effects in 50 year old female
Reported by a physician from Mexico on 2012-03-30
Patient: 50 year old female, weighing 65.5 kg (144.1 pounds)
Reactions: Interstitial Lung Disease
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Taxotere
Start date: 2012-01-18
End date: 2012-01-18
Taxotere
Start date: 2012-02-09
End date: 2012-02-09
Taxotere
Start date: 2012-01-18
End date: 2012-01-18
Taxotere
Start date: 2012-02-09
End date: 2012-02-09
Cyclophosphamide
Dosage: 3 cycles.
Taxotere
Start date: 2012-01-18
End date: 2012-01-18
Taxotere
Start date: 2012-03-09
End date: 2012-03-09
Fluorouracil
Dosage: 3 cycles.
Taxotere
Start date: 2012-02-09
End date: 2012-02-09
Taxotere
Start date: 2012-03-09
End date: 2012-03-09
Taxotere
Start date: 2012-03-09
End date: 2012-03-09
Epirubicin
Dosage: 3 cycles.
Page 1 Next >>
|
